Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Nucl Cardiol. 2017 May 15;24(5):1517–1529. doi: 10.1007/s12350-017-0899-7

Table 5.

Summary of sampling requirements

Parameter Optimal Alternate Effect of Alternate Parameter Values
Number of Phases 2 3 or 4 Less than 8% space and time savings
Blood Phase Interval 0–120sec
Tissue Phase Interval 120–360sec
Blood Phase Frame Duration (T1) 5sec 10sec Up to 12% MBF and MFR change
Tissue Phase Frame Duration (T2) 125sec 120, 60, or 30sec Less than 5% in MBF and MFR change